TB support in Swaziland

Eswatini

Eswatini (formerly Swaziland) has one of the world’s highest rates of HIV, with nearly one in three adults living with the disease. However, around 80 per cent of people with TB in Eswatini are HIV positive.

Estimates suggest that HIV incidence rates in Eswatini have fallen in recent years, as significant progress has been made in improving the number of people receiving antiretroviral (ARV) treatment.

We continue to help more HIV patients access ARV treatment through the ’test and start’ strategy. A team has been piloting ‘test and start’ in the Nhlangano project; after HIV testing, ARV treatment was offered to more than 1,700 people after a positive HIV diagnosis to immediately start treatment.

We now treat patients with extensively drug-resistant TB (XDR-TB), and those developing severe side effects, using the promising new drugs bedaquiline and delamanid in combination with repurposed drugs.

MSF teams are currently responding to the coronavirus COVID-19 pandemic in Eswatini.

In 2019
 
Eswatini

A new ward to treat patients with drug resistant tuberculosis

Project Update 29 Sep 2011
 
South Africa

HIV patients refuse to be sidelined by international community in unique football tournament

Press Release 2 Jul 2010
 
Eswatini

TB and HIV/AIDS in Swaziland

Project Update 28 Oct 2009